Back
Daktronics Vs. Avidity Biosciences Industry Stock Comparison
Buy
58
DAKT
Daktronics
Last Price:
14.91
Seasonality Move:
7.87%
Sell
42
RNA
Avidity Biosciences
Last Price:
46.75
Seasonality Move:
39.98%
Buy
58
Daktronics (DAKT)
is a Buy
Is Daktronics a Buy, Sell or Hold?
- The current Daktronics [DAKT] share price is $15.14. The Score for DAKT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- DAKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $47.13. The Score for RNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAKT Stock Price Chart
What is Daktronics's stock price today?
-
The Daktronics share price today is $15.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight selling pressure.
DAKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 73.96 | Buy |
Chaikin Money Flow: | 222046 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.84 - 14.14) | Buy |
Bollinger Bands (100): | (12.46 - 14.72) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 55.24 | Buy |
Chaikin Money Flow: | -248351 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.93 - 47.71) | Buy |
Bollinger Bands (100): | (41.2 - 46.58) | Buy |
DAKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.01 | Buy |
20-day SMA: | 13.6 | Buy |
50-day SMA: | 13.04 | Buy |
200-day SMA: | 11.6 | Buy |
8-day EMA: | 14.29 | Buy |
20-day EMA: | 13.74 | Buy |
50-day EMA: | 13.44 | Buy |
200-day EMA: | 11.94 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.33 | Buy |
20-day SMA: | 45.94 | Buy |
50-day SMA: | 44.62 | Buy |
200-day SMA: | 33.49 | Buy |
8-day EMA: | 46.11 | Buy |
20-day EMA: | 45.68 | Buy |
50-day EMA: | 44.8 | Buy |
200-day EMA: | 35.08 | Buy |
Daktronics Earnings Growth & DAKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.09 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Daktronics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |